20-44619848-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000022.4(ADA):c.1079-1G>A variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000022.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA | NM_000022.4 | c.1079-1G>A | splice_acceptor_variant, intron_variant | ENST00000372874.9 | NP_000013.2 | |||
ADA | NM_001322051.2 | c.1007-1G>A | splice_acceptor_variant, intron_variant | NP_001308980.1 | ||||
ADA | NM_001322050.2 | c.674-1G>A | splice_acceptor_variant, intron_variant | NP_001308979.1 | ||||
ADA | NR_136160.2 | n.1106-1G>A | splice_acceptor_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA | ENST00000695956.1 | c.245G>A | p.Arg82Lys | missense_variant | 3/3 | ENSP00000512285.1 | ||||
ADA | ENST00000372874.9 | c.1079-1G>A | splice_acceptor_variant, intron_variant | 1 | NM_000022.4 | ENSP00000361965.4 | ||||
ADA | ENST00000695995.1 | c.689-1G>A | splice_acceptor_variant, intron_variant | ENSP00000512318.1 | ||||||
ADA | ENST00000695991.1 | c.617-1G>A | splice_acceptor_variant, intron_variant | ENSP00000512314.1 | ||||||
ADA | ENST00000696038.1 | n.*1286G>A | non_coding_transcript_exon_variant | 9/9 | ENSP00000512344.1 | |||||
ADA | ENST00000696038.1 | n.*1286G>A | 3_prime_UTR_variant | 9/9 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250986Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135700
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461850Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727224
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 16, 2022 | Variant summary: ADA c.1079-1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Computational tool predictions for the splicing effect of this variant were inconclusive. Since the current variant is located at the last intron-exon junction, it is not expected to cause nonsense mediated decay (NMD), but is predicted to cause a truncation of the encoded protein, removing the last exon (and likely replacing it with an incorrect sequence). The last exon consists of only four amino acids, and a functional study demonstrated that these were dispensable for protein function, on the other hand an extension of the protein by adding a 43-residue tail rendered the protein unstable (PMID 11807006). The variant allele was found at a frequency of 4e-06 in 250986 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1079-1G>A in individuals affected with Severe Combined Immunodeficiency and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at